Literature DB >> 20109642

Fecal incontinence.

Anders Mellgren1.   

Abstract

Fecal incontinence is a debilitating and socially embarrassing condition. Significant advances in the evaluation and treatment of this condition have been made in recent years, and several new treatment modalities are in the pipeline to be made available to affected patients. This article reviews the workup and operative and nonoperative management of fecal incontinence, and it discusses the emerging role of methods, such as bioinjectable agents and sacral nerve stimulation. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2010        PMID： 20109642     DOI： 10.1016/j.suc.2009.10.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  3 in total

1.  Does preoperative anal physiology testing or ultrasonography predict clinical outcome with sacral neuromodulation for fecal incontinence?

Authors:  Yarini Quezada; James L Whiteside; Tracy Rice; Mickey Karram; Janice F Rafferty; Ian M Paquette
Journal:  Int Urogynecol J       Date:  2015-05-28       Impact factor: 2.894

Review 2.  Dextranomer in stabilized sodium hyaluronate (Solesta®): in adults with faecal incontinence.

Authors:  Sheridan M Hoy
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

3.  An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence.

Authors:  Giuseppe Dodi; Johannes Jongen; Fernando de la Portilla; Manoj Raval; Donato F Altomare; Paul-Antoine Lehur
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.